Bal Pharma, pharmaceutical manufacturer and exporter, by launching new drugs has posted 60.2 per cent higher profits at Rs 1.57 crore in the first quarter (Q1) ended June 30, 2008 of financial year 2008-09 as compared to Rs 98.70 lakhs registered in the corresponding period last year.
The company's revenues are up 42.45 per cent at Rs 28.42 crore in Q1 as against Rs 19.95 crore registered same period last year.
Commenting on the results Shailesh Siroya, Managing Director, Bal Pharma said, "In the first quarter, the company has offered seven products to the Indian market and we plan to do Rs 10 crore sales in the first year.”
The new products entered the Indian market are Aziwin AX, Glyvog, Telong, Telong H, Rabifix 20, Rabifix D & Balpro Syrup. The company plans to enter 15 new countries within the next financial year."
Top Section
Explore Business Standard